Prevention and management of pressure ulcers

Reviews in Clinical Gerontology

Volumn 11, Issue 2, 2001, Pages 115-130

  Thomas, David R ^a,b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTACID AGENT; ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE; GRANULEX; GROWTH FACTOR; HEXACHLOROPHENE; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; NEOMYCIN; NITROFURAL; POVIDONE IODINE; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; TRIAMCINOLONE ACETONIDE;

CLINICAL TRIAL; DEBRIDEMENT; DECUBITUS; DIABETIC FOOT; FOOT ULCER; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUTRITIONAL STATUS; REVIEW; RISK ASSESSMENT; SKIN ULCER; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 0034764146     PISSN: 09592598     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0959259801011236     Document Type: Review

References (126)

1. Pressure sores
2. National pressure ulcer prevalence survey
3. The prevalence of pressure sores
4. Atheromatous embolism
5. Blue toe syndrome: Causes and management
6. Fourth national pressure ulcer prevalence survey
7. Pressure ulcers: The Minimum Data Set and the Resident Assessment
8. Prevalence of pressure damage in hospital patients in the UK
9. Definitions and guidelines for assessment of wounds and evaluation of healing
10. Impaired migration of epidermal cells from decubitus ulcers in cell culture: A cause of protracted wound healing?
11. Immunologic reactions in chronic wounds
12. A randomized trial of low-air-loss beds for treatment of pressure ulcers
13. The epidemiology and natural history of pressure ulcers in elderly nursing home residents
14. Pressure sores among hospitalized patients
15. The short-term outcome of pressure sores
16. A prospective study of pressure-sore risk among institutionalized elderly
17. The problem of pressure sores in a nursing home population: Statistical data
18. Pressure ulcers in the elderly: Prevention and treatment utilizing the team approach
19. Pressure ulcers and risk of death
20. The Norton score: An early warning of pressure sores?
21. The Braden scale for predicting pressure sore risk
22. Pressure sores in the elderly: Can this outcome be improved?
23. A comparison of patient risk for pressure ulcer development with nursing use of preventive interventions
24. The Dutch pressure sore assessment score or the Norton scale for identifying at-risk nursing home patients?
25. Pressure sores: A risk assessment card
26. Predicting pressure sore risk with the Norton, Braden, and Waterlow Scales in a Hong Kong rehabilitation hospital
27. Hospital-acquired pressure ulcers: Risk factors and use of preventive devices
28. Underutilization of pressure ulcer risk assessment in hip fracture patients
29. Strategies for preventing pressure ulcers
30. The prevention and treatment of pressure sores
31. Predicting the risk of pressure ulcers in critically ill patients
32. Implementation of risk assessment and classification of pressure ulcers as quality indicators for patients with hip fractures
33. The limits of pressure sore prevention
34. Are we improving the quality of nursing home care: The case of pressure ulcers
35. Reducing nosocomial pressure ulcers in an acute care facility
36. Nursing assessment: Impact on type and cost of interventions to prevent pressure ulcers
37. Pressure ulcer development in the VA: Characteristics of nursing homes providing best care
38. Malnutrition, tube feeding and pressure sores: Data are incomplete
39. Prospective audits of quality of PEM recognition and nutritional support in critically ill elderly patients
40. A multi-center trial of the effects of oral nutritional supplementation in critically ill older inpatients
41. Pressure sores and tube feeding in patients with a fracture of the hip: A randomized clinical trial
42. The role of nutrition in prevention and healing of pressure ulcers
43. Lack of nutrition in AHCPR prevention guideline
44. The effect of very high-protein liquid formula (Replete) on decubitus ulcer healing in long-term tube-fed institutionalized patients. Investigators Final Report 1990
45. The importance of dietary protein in healing pressure ulcers
46. Human protein requirements: Assessment of the adequacy of the current Recommended Dietary Allowance for dietary protein in elderly men and women
47. A physiologic bases for the provision of fuel mixtures in normal and stressed patients
48. Nutritional aspects of ascorbic acid: Uses and abuses
49. Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers
50. Zinc nutriture in the elderly in relation to taste acuity, immune response, and wound healing
51. Discovery of human zinc deficiency and studies in an experimental human model
52. Preventing pressure sores in geriatric patients
53. A review of pressure damage prevention strategies
54. Air-fluidized beds or conventional therapy for pressure sores: A randomized trial
55. Air-fluidized bed treatment of nursing home patients with pressure sores
56. Pressure ulcers: Local wound care
57. Pressure ulcer management in home health care: Efficacy and cost effectiveness of moisture vapor permeable dressing
58. A randomized trial of Cadexomer iodine in decubitus ulcers
59. Improved pressure sore healing with hydrocolloid dressings
60. New method for assessing epidermal wound healing. The effects of triamcinolone acetonide and polyethylene film occlusion
61. The fine structure of the interrelationship of cells in the human epidermis
62. Formation of scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig
63. Occlusive dressings: Therapeutic agents and effects on drug delivery
64. Experiences with biosynthetic dressings
65. Physiology, immunology and clinical efficacy of an adherent polyurethane wound dressing Op-site
66. Hydrocolloid occlusive dressing management of leg ulcers
67. Treatment of chronic leg ulcers with Opsite
68. Clinical and laboratory investigation of the compositions and properties of human skin wound exudate under semi-permeable dressings
69. Occlusive wound dressings to prevent bacterial invasion and wound infection
70. Occlusive dressings and wound healing
71. Cutaneous ulcer therapy
72. Care of pressure sores: A controlled study of the use of a hydrocolloid dressing compared with wet saline gauze compresses
73. A comparison of the efficacy and cost-effectiveness of two methods of managing pressure ulcers
74. Hydrocolloid versus saline gauze dressings in treating pressure ulcers: A cost-effective analysis
75. Peptide growth factors and inflammation, tissue repair and cancer
76. Growth factors in wound healing
77. Occlusive wound dressings: Why, when, which?
78. Moist environment: Matching the dressing to the wound
79. Studies in the management of the contaminated wound. V. An assessment of the effectiveness of pHisohex and Betadine surgical scrub solutions
80. Comparison of common topical agents for wound treatment: Cytotoxicity for human fibroblasts in culture
81. Pluronic F-68: A promising new skin wound cleanser
82. Influence of cationic detergents on tensile strength of healing skin wounds in the rat
83. Topical antimicrobial toxicity
84. Comparison of the wet-to-dry dressing and a copolymer starch in the management of derided pressure sores
85. Decubitus ulcer care: A comparative study
86. A wound model for ischemic ulcers in the guinea pig
87. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide
88. Comparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds
89. Debridement of dermal ulcers with collagenase
90. Collagenase therapy for decubitus ulcers
91. An economical enzymatic debriding agent for chronic skin ulcers
92. Decubitus ulcers: Healing effect of an enzymatic spray
93. Chemical debridement of pressure ulcers: A prospective, randomized, comparative trial of collagenase and papain/urea formulations
94. Recombinant human derived growth factor - BB for the treatment of chronic pressure ulcers
95. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
96. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores
97. Experimental staphylococcal infections in the skin of man
98. Bacterial growth and skin graft survival
99. What is infection?
100. Investigation into the microbial flora of healing and non-healing decubitus ulcers
101. Effect of aerobic and anaerobic germs on the healing of decubitus ulcers
102. Quantitative microbiology of pressure sores in different stages of healing
103. Repair and antibacterial effects of topical antiseptic agents in vivo
104. Relationship of quantitative wound bacterial counts to healing of decubiti: Effect of topical gentamicin
105. Comparison of silver sulfadiazine, povidone-iodine and physiologic saline in the treatment of chronic pressure ulcers
106. Comparison of topical antibiotic ointments, a wound protectant, and antiseptics for the treatment of human blister wounds contaminated with Staphylococcus aureus
107. Pressure sores in the elderly: Topical metronidazole therapy for anaerobically infected pressure sores
108. Occlusive dressings: A microbiological and clinical review
109. Bacteremia associated with decubitus ulcers
110. Sepsis associated with decubitus ulcers
111. Osteomyelitis beneath pressure sores
112. Osteomyelitis associated with pressure ulcers
113. Computed tomography of pressure ulcers, pelvic abscess, and osteomyelitis in patients with spinal cord injury
114. The diagnosis of osteomyelitis in patients with pressure sores
115. Existing tods: Are they meeting the challenge of pressure ulcer healing?
116. Pressure ulcer scale for healing: Derivation and validation of the PUSH tool
117. Surgical correction of pressure ulcers in an urban center: Is it efficacious?
118. Efficacy of operative cure in pressure sore patients
119. Outcomes in surgical intervention
120. Management of Stage III pressure ulcers in moderately demented nursing home residents
121. Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study
122. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of Stage 3 and 4 pressure ulcers
123. Safety and effect of topical recombinant human interleukin-1-β in the management of pressure sores
124. Sequential cytokine therapy for pressure ulcers: Clinical and mechanistic response